In its January 2014 issue brief, amfAR, The Foundation for AIDS Research says investing now in global AIDS efforts “is essential to maximize the return on investments.” The brief asserts, “Investing now to bring essential HIV prevention and treatment services to scale enables the global response to outpace the epidemic itself, saving both lives and money over the long run. By contrast, shortchanging HIV spending now merely allows the epidemic to expand, adding to long-term health and economic costs” (1/27).